| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |